Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review
暂无分享,去创建一个
P. Horby | M. Clarke | L. Sigfrid | G. Carson | S. Ismail | N. Gobat | E. Harriss | P. Bannister | K. Longuere | S. Regmi | Katherine Maskell | Shelui Collinson | Claire Blackmore
[1] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.
[2] Michael Proschan,et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. , 2019, The New England journal of medicine.
[3] H. Goossens,et al. “Advancing preparedness for clinical research during infectious disease epidemics” Nina Gobat, John Amuasi, Yazdan Yazdanpanah, Louise Sigfrid, Hugh Davies, John-Paul Byrne, Gail Carson, Christopher Butler, Alistair Nichol and Herman Goossens. ERJ Open Res 2019; 5: 00227-2018. , 2019, ERJ Open Research.
[4] Herman Goossens,et al. Advancing preparedness for clinical research during infectious disease epidemics , 2019, ERJ Open Research.
[5] Colin Simpson,et al. The UK's pandemic influenza research portfolio: a model for future research on emerging infections. , 2018, The Lancet. Infectious diseases.
[6] H. Goossens,et al. Preparedness for clinical research during pandemics: a perspective from the Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) , 2018, The Lancet.
[7] J. McGowan,et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.
[8] Wichor M Bramer,et al. A systematic approach to searching: an efficient and complete method to develop literature searches , 2018, Journal of the Medical Library Association : JMLA.
[9] H. Feldmann,et al. Ebola: Lessons on Vaccine Development. , 2018, Annual review of microbiology.
[10] P. Horby. Improving preparedness for the next flu pandemic , 2018, Nature Microbiology.
[11] D. Watson-Jones,et al. EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country , 2018, Clinical trials.
[12] A. Schuchat,et al. Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola , 2018, The Journal of infectious diseases.
[13] J. Lundgren,et al. Rigorous Clinical Trial Design in Public Health Emergencies Is Essential , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Lauren Ancel Meyers,et al. Preprints: An underutilized mechanism to accelerate outbreak science , 2018, PLoS Medicine.
[15] S. Lees,et al. "We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial. , 2018, Social science & medicine.
[16] Tamba E. M’bayo. Understanding West Africa’s Ebola Epidemic: Towards a Political Economy , 2018 .
[17] P. Horby,et al. Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] K. Hood,et al. Talking to the people that really matter about their participation in pandemic clinical research: A qualitative study in four European countries , 2017, Health expectations : an international journal of public participation in health care and health policy.
[19] S. Hodgson. Understanding West Africa’s Ebola epidemic , 2017, Medicine, conflict, and survival.
[20] P. P. Rosario,et al. Ethical challenges for international collaborative research partnerships in the context of the Zika outbreak in the Dominican Republic: a qualitative case study , 2017, Health Research Policy and Systems.
[21] L. Fernández-Luque,et al. Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news , 2017, BMC Public Health.
[22] Daniel J. Hurst. Benefit Sharing in a Global Context: Working Towards Solutions for Implementation. , 2017, Developing world bioethics.
[23] M. Lipsitch,et al. Improving vaccine trials in infectious disease emergencies , 2017, Science.
[24] E. Alirol,et al. Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic , 2017, BMC medical ethics.
[25] Marie Paule Kieny,et al. WHO R&D Blueprint: a global coordination mechanism for R&D preparedness , 2017, The Lancet.
[26] G. Keusch,et al. Clinical trials during epidemics , 2017, The Lancet.
[27] P. Maes,et al. Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa , 2017, PLoS neglected tropical diseases.
[28] S. Shrivastava,et al. Strengthening research and development activities to effectively contain the epidemics of infectious diseases: World health organization , 2017 .
[29] S. Shrivastava,et al. Upscaling of interventions for the control of Echinococcosis and its associated complications , 2017 .
[30] J. Pierson,et al. Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergency , 2017, The American journal of tropical medicine and hygiene.
[31] S. Glismann,et al. The ADVANCE Code of Conduct for collaborative vaccine studies. , 2017, Vaccine.
[32] D. Wendler,et al. The Guinea Phase III Ebola Vaccine Trial: Lessons for Research Ethics Review in Public Health Emergencies. , 2017, IRB.
[33] N. Pollock,et al. Evaluating Novel Diagnostics in an Outbreak Setting: Lessons Learned from Ebola , 2017, Journal of Clinical Microbiology.
[34] B. Light,et al. Time required to initiate outbreak and pandemic observational research☆☆☆ , 2017, Journal of Critical Care.
[35] M. Molyneux. New ethical considerations in vaccine trials , 2017, Human vaccines & immunotherapeutics.
[36] H. Draper,et al. A Systematic Review of Ebola Treatment Trials to Assess the Extent to Which They Adhere to Ethical Guidelines , 2017, PLoS ONE.
[37] R. Peeling,et al. ZikaPLAN: Zika Preparedness Latin American Network , 2017, Global health action.
[38] Raffaella Ravinetto,et al. Research Ethics Governance in Times of Ebola , 2016, Public health ethics.
[39] D. Shaw,et al. Publication ethics in public health emergencies , 2016, Journal of public health.
[40] P. Horby,et al. Modernising epidemic science: enabling patient-centred research during epidemics , 2016, BMC Medicine.
[41] S. Lees,et al. Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone , 2016, BMC Public Health.
[42] K. Hood,et al. Public attitudes towards research participation during an infectious disease pandemic: a qualitative study across four European countries , 2016, The Lancet.
[43] P. Horby,et al. Experimental Treatment of Ebola Virus Disease with Brincidofovir , 2016, PloS one.
[44] C. Rivers,et al. Make Data Sharing Routine to Prepare for Public Health Emergencies , 2016, PLoS medicine.
[45] Robert Pinner,et al. Implementing an Ebola Vaccine Study - Sierra Leone. , 2016, MMWR supplements.
[46] L. Wehrlen,et al. Beating the odds: Successful establishment of a Phase II/III clinical research trial in resource-poor Liberia during the largest-ever Ebola outbreak , 2016, Contemporary clinical trials communications.
[47] E. Hwang,et al. Coordinating funding in public health emergencies , 2016, The Lancet.
[48] M. Kieny,et al. Regulatory policy for research and development of vaccines for public health emergencies , 2016, Expert review of vaccines.
[49] G. Leung,et al. Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola , 2016, PLoS medicine.
[50] M. Kieny,et al. On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa. , 2016, Current opinion in virology.
[51] S. Lees,et al. Implementing a novel community engagement system during a clinical trial of a candidate Ebola vaccine within an outbreak setting , 2016 .
[52] Annette Rid,et al. Ethical Rationale for the Ebola "Ring Vaccination" Trial Design. , 2016, American journal of public health.
[53] R. Murphy,et al. Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions , 2016, The American journal of tropical medicine and hygiene.
[54] A. Delamou,et al. Multiple ethical review in North-South collaborative research: the experience of the Ebola-Tx trial in Guinea. , 2016, Indian journal of medical ethics.
[55] Scott M Berry,et al. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response , 2016, Clinical trials.
[56] Christopher W Woods,et al. Ebola clinical trials: Five lessons learned and a way forward , 2016, Clinical trials.
[57] L. Moses,et al. Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation , 2016, Clinical trials.
[58] A. Levine. Academics are from Mars, humanitarians are from Venus: Finding common ground to improve research during humanitarian emergencies , 2016, Clinical trials.
[59] Tony Vangeneugden,et al. Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges , 2016, Clinical trials.
[60] M. Cavaleri,et al. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola , 2016, Clinical trials.
[61] A. Abayomi,et al. Taking the bull by the horns: Ethical considerations in the design and implementation of an Ebola virus therapy trial , 2015, Social Science & Medicine.
[62] Nayha Sethi,et al. Conducting research in the context of global health emergencies , 2016 .
[63] Lawrence O Gostin,et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola , 2015, The Lancet.
[64] T. Lang. Ebola: Embed research in outbreak response , 2015, Nature.
[65] John-Arne Røttingen,et al. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola , 2015, BMJ : British Medical Journal.
[66] B. Haire,et al. Stakeholders’ engagement with Ebola therapy research in resource limited settings , 2015, BMC Infectious Diseases.
[67] Lauren Ancel Meyers,et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. , 2015, The Lancet. Infectious diseases.
[68] G. Apolone,et al. Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? , 2015, The Lancet Infectious Diseases.
[69] G. Rodier,et al. Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out , 2015, The Lancet.
[70] W. Lim,et al. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. , 2015, Health technology assessment.
[71] L. Rosella,et al. The ethics of sharing preliminary research findings during public health emergencies: a case study from the 2009 influenza pandemic. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[72] W. Lim,et al. Randomised trials during a public health crisis, such as pandemic flu: a case study for a model of ‘off the shelf' ready-to-go trials , 2013, Trials.
[73] J. Marshall,et al. Participation of ICUs in Critical Care Pandemic Research: A Province Wide, Cross-Sectional Survey* , 2013, Critical care medicine.
[74] Francis Collins,et al. Research as a part of public health emergency response. , 2013, The New England journal of medicine.
[75] J. Langley,et al. Strategies for successful rapid trials of influenza vaccine , 2011, Clinical trials.
[76] D. Cook,et al. Costs Of Clinical Research Preparation For The H1N1 Pandemic In Canada: A Single Center, Multi-Site Analysis , 2011, ATS 2011.
[77] D. Annane,et al. Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic , 2011, Intensive Care Medicine.
[78] C. Simon,et al. Ethical problems in conducting research in acute epidemics: the Pfizer meningitis study in Nigeria as an illustration. , 2010, Developing world bioethics.
[79] C. Sprung,et al. Early observational research and registries during the 2009–2010 influenza A pandemic , 2010, Critical care medicine.
[80] C. Sprung,et al. Clinical research ethics for critically ill patients: A pandemic proposal , 2010, Critical care medicine.
[81] T. Walley,et al. Research funding in a pandemic , 2010, The Lancet.
[82] S. Faust,et al. Expediting clinical trials in a pandemic , 2009, BMJ : British Medical Journal.
[83] Samia Hurst,et al. Research Ethics and International Epidemic Response: The Case of Ebola and Marburg Hemorrhagic Fevers , 2009 .
[84] J. Farrar,et al. The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. , 2008, Antiviral research.
[85] Benjamin Jeffs,et al. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. , 2008, Antiviral research.
[86] E. von Elm,et al. Full publication of results initially presented in abstracts. , 2007, The Cochrane database of systematic reviews.